Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
APC8015 and Bevacizumab in Treating Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1